← Leaderboards
Erin Kimbrel
Ocata Therapeutics, Inc.
$112,820
Attributed
$225,639
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$225,639 · 1
By mechanism
R43$225,639 · 1
Top collaborators
- Robert P Lanza1 shared
Most similar at Ocata Therapeutics, Inc.
Same institution · by research overlap
- Dana Larocca$2,270,692
Others in their field
Top investigators on “Allogenic”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Mary M Horowitz · Medical College Of Wisconsin$47,632,939
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$40,815,122
- Marcel R M Van Den Brink · Sloan-Kettering Institute For Cancer Res$39,678,762
- Bruce R. Blazar · University Of Minnesota$37,193,531
- Megan Sykes · Columbia University Health Sciences$33,587,479
Research focus
AllogenicAnimal ModelAnimalsAntibodiesAntigen-Antibody ComplexAutoimmune DiseasesAutoimmune ProcessAutoimmunityBaseBiological MarkersBiotechnologyBlood Urea NitrogenBody WeightBone MarrowCellsCell TherapyCell TransplantationCellular TargetingCessation Of LifeChemistryClinical TrialsCombatCommercializationAdult